Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
7.42
+0.57 (8.32%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $541.57 million as of March 9, 2026. Its market cap has increased by 306.27% in one year.
Market Cap
541.57M
Enterprise Value
427.26M
1-Year Change
306.27%
Ranking
Category
Stock Price
$7.42
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $541.57M, an increase of 99.58%. That is a compound annual growth rate of 34.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 499.96M | -31.02% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 592.12M |
| Larimar Therapeutics | 590.19M |
| Design Therapeutics | 578.75M |
| MeiraGTx Holdings | 575.51M |
| Verastem | 560.39M |
| Alpha Tau Medical | 547.82M |
| Allogene Therapeutics | 546.09M |
| YD Bio | 545.33M |